In the world of healthcare, where every decision can have far-reaching consequences, the legal battles between insurance providers and regulatory bodies are not just about money; they're about the very principles of fairness and equity. The recent lawsuits filed by SCAN Health Plan, Alignment Healthcare, and Elevance Health against the Centers for Medicare & Medicaid Services (CMS) over the recalculation of Medicare Advantage star ratings exemplify this tension. These cases are not merely about financial gains or losses; they're about the integrity of the healthcare system and the trust between providers and patients.
The Background
The CMS had initially recalculated the star ratings for the 2026 Medicare Advantage plans following a court victory for Clover Health. This recalculation was based on a Georgia judge's decision to vacate a set of 10 measures that CMS had implemented, arguing that they exceeded statutory authority. However, the CMS only partially applied this ruling, excluding the second set of measures when recalculating scores for insurers other than Clover Health.
SCAN Health Plan's Argument
SCAN Health Plan, in its lawsuit, argues that CMS's decision to exclude the second set of measures when recalculating SCAN's scores violates governing law. They believe that if the first set of measures was invalid, the second set should also be excluded, as they were part of the same set of regulations. This argument is not just about legal technicalities; it's about ensuring that the recalculation is consistent and fair across the board.
Alignment Healthcare's Perspective
Alignment Healthcare, in its lawsuit, takes a broader view, arguing that CMS's failure to adhere to the Georgia court's decision in full for other payers has deprived the company of more than $50 million in payments and imposed significant reputational and competitive harms. This perspective highlights the broader implications of the CMS's decision, not just for SCAN but for the entire industry.
Elevance Health's Complaint
Elevance Health, in its lawsuit, takes a more direct approach, arguing that CMS's refusal to recalculate its scores with the same methodology used for Clover Health has directly disadvantaged the company in markets where the two MAOs compete for the same Medicare beneficiaries. Elevance believes that if the same standards were applied fairly, it would see $115 million more in quality bonus payments and maintain a more competitive position.
The Broader Implications
These lawsuits raise deeper questions about the integrity of the star ratings program and the fairness of the CMS's decision-making process. They also highlight the tension between regulatory bodies and healthcare providers, and the need for a consistent and equitable approach to the evaluation of Medicare Advantage organizations. The CMS's decision to recalculate scores only for plans that would see an increase raises concerns about favoritism and selective application of the law.
Personal Interpretation
From my perspective, these lawsuits are not just about the money; they're about the principles of fairness and equity in healthcare. The CMS's decision to recalculate scores only for plans that would see an increase raises serious questions about the integrity of the star ratings program. It suggests a selective application of the law, which can undermine the trust between providers and patients. Personally, I think that the CMS should have applied the same methodology to all plans, regardless of the impact on their scores.
Conclusion
The legal battles between SCAN Health Plan, Alignment Healthcare, and Elevance Health against the CMS over the recalculation of Medicare Advantage star ratings are not just about financial gains or losses; they're about the very principles of fairness and equity in healthcare. These cases highlight the need for a consistent and equitable approach to the evaluation of Medicare Advantage organizations and the importance of maintaining the integrity of the star ratings program for beneficiaries, providers, and health plans. The outcome of these lawsuits will have significant implications for the future of healthcare in the United States.
